Vellum Health Closes Series A Round, Launches Innovative Mobile IV Platform

Deal News | Jun 26, 2025 | FCA Venture Partners

Vellum Health, a company offering mobile healthcare services, successfully completed its Series A funding round, spearheaded by FCA Venture Partners. The funding included contributions from Green Park & Golf Ventures as well as seed round angel investors. Vellum Health specializes in providing mobile intravenous (IV) services, infusion therapy, and on-site transfusion services. Their services target patients in skilled nursing facilities, long-term acute care centers, and home settings, aiming to reduce unnecessary hospitalizations and enhance patient outcomes by facilitating healthcare delivery in cost-effective and convenient environments.

Sectors

  • Healthcare
  • Venture Capital

Geography

  • United States – Both Vellum Health and FCA Venture Partners operate primarily in the United States.

Industry

  • Healthcare – The article pertains to Vellum Health's focus on healthcare delivery via mobile IV services.
  • Venture Capital – The article discusses the Series A funding round led by FCA Venture Partners, a venture capital firm.

Financials

  • Series A Round – The stage of funding closed by Vellum Health, led by FCA Venture Partners.

Participants

NameRoleTypeDescription
Vellum HealthTarget CompanyCompanyA mobile healthcare platform that provides advanced IV services.
FCA Venture PartnersLead InvestorPE FirmA venture capital firm that led the Series A funding round for Vellum Health.
Green Park & Golf VenturesCo-investorCompanyA venture capital firm that participated in the Series A funding round.
Angel InvestorsInvestorsPeopleSeed round investors who provided follow-on investment in the Series A round.